Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The investigator for this study is Dr. Jessica Lunsford-Avery from the Department of Psychiatry.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Child ages 6-9 2. Meet criteria for a primary psychiatric diagnosis of DSM-5 ADHD, any presentation 3. Intellectual functioning \>80 4. Healthy (i.e., no major medical problems) 5. If applicable, willingness to suspend use of melatonin during the study period Who Should NOT Join This Trial: 1. Meet DSM-5 criteria for psychosis, bipolar, or autism spectrum disorders 2. Diagnosis of occult sleep disorders, including sleep apnea or restless leg syndrome 3. Medication for sleep other than melatonin 4. Plans to initiate stimulant medication during the study period Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Child ages 6-9 2. Meet criteria for a primary psychiatric diagnosis of DSM-5 ADHD, any presentation 3. Intellectual functioning \>80 4. Healthy (i.e., no major medical problems) 5. If applicable, willingness to suspend use of melatonin during the study period Exclusion Criteria: 1. Meet DSM-5 criteria for psychosis, bipolar, or autism spectrum disorders 2. Diagnosis of occult sleep disorders, including sleep apnea or restless leg syndrome 3. Medication for sleep other than melatonin 4. Plans to initiate stimulant medication during the study period

Locations (1)

Duke University Medical Center
Durham, North Carolina, United States